2. INTRODUCTION
Neuroendocrine tumors (also called NETs) represent about 0.5% of
all newly diagnosed malignancies.
Neuroendocrine tumors are rare, slow-growing tumors that originate
in cells of the diffuse neuroendocrine system. They occur most
frequently in tissues derived from the embryonic gut.
3. PATHOLOGY OF NET:
• Neuroendocrine tumors have specific histological and
immunohistochemical features based on their anatomical location and
endocrine cell type.
• In the gastric or intestinal wall, they may occur as firm white, yellow, or
gray nodules and may be intramural masses or may protrude into the
lumen as polypoid nodules.
5. • Neuroendocrine cells have uniform nuclei
and abundant granular or faintly staining
(clear) cytoplasm.
• They are present as solid or small
trabecular clusters or are dispersed among
other cells, which may make them difficult
to recognize in sections stained with
hematoxylin and eosin; immunostaining
enables their exact identification.
6. NEUROENDOCRINE NEOPLASM / TUMOR
(WHO CLASSIFICATION - 2019)
• 1-Neuroendocrine tumor (NET):
• NET, grade 1 (G1): well differentiated low grade
• NET, G2: well differentiated intermediate grade
• NET, G3: well differentiated high grade
• 2-Neuroendocrine carcinoma, small cell type (SCNEC)
• 3-Neuroendocrine carcinoma, large cell type (LCNEC)
• 4-Mixed neuroendocrine – non-neuroendocrine neoplasm (MiNEN)
8. CASE-1
• Female ; 36 years old, she has a palpable rectal mass, submucosal
“mostly lipoma”
• Received at the histopathology department as one polypoid mass
measuring 1.2 x 1 x 0.8 cm, with firm consistency and yellowish
color on cut section.
13. CASE - 2
• Male patient , 62 years old
• Clinically presented with abdominal pain and conistipation
• Gastric and duodenal endoscopic biopsy and gastric polyp
endoscopic biopsy
14. • The gastric polyp show antral gastric mucosa overlying well
circumscribed tumor composed of nests of cells surrounded by
abundant vascular stroma
• The case is changing; differential diagnosis included:
1- GIST
2- Gastric carcinoma
3- Neuroendocrine tumor
4- Inflammatory myo-fibrobastic tumour